SUBSCRIBE
SUBSCRIBE
News   Policy

IntelliPharmaCeutics Provides Additional Update on Activities Related to 30mg Generic Version of Focalin XR(R)

April 6, 2011 | 
1 min read

TORONTO, April 5, 2011 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) today announced the following with regard to its generic drug commercialization activities.

Legal
MORE ON THIS TOPIC
The EMA's former headquarters in London
Europe
Biogen, Eisai Continue Leqembi’s European Rally as CHMP Reaffirms Positive Opinion
March 3, 2025
 · 
2 min read
 · 
Tristan Manalac
Editorial
Transparency Missing in Action at HHS Despite Leaders’ Calls for Clarity
February 28, 2025
 · 
4 min read
 · 
Heather McKenzie
Pictured: A syringe broken in half with long hallway in background/Nicole Bean for BioSpace
Vaccines
Meeting of FDA’s Vaccines Advisory Panel Canceled as Kennedy Settles Into HHS
February 27, 2025
 · 
2 min read
 · 
Tristan Manalac
External view of the U.S. Capitol building
Government
Congress Re-Introduces EPIC Act to Remove IRA’s ‘Pill Penalty’
February 26, 2025
 · 
2 min read
 · 
Tristan Manalac